Tainan, Taiwan

Piin-Jye Harn

This inventor holds 4 USPTO granted patents, plus 2 CIPO patents and 4 EPO patents. Top assignee: Scinopharm Taiwan, Ltd.. Active years: 2008-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Piin-Jye Harn. Retrieved from https://idiyas.com/inventor/piin-jye-harn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0


 

Average Co-Inventor Count = 2.3

ph-index = 1


Company Filing History:


Years Active: 2008-2012

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Piin-Jye Harn

Introduction

Piin-Jye Harn is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel crystalline forms of important compounds. With a total of 4 patents to his name, Harn's work has the potential to impact cancer treatment and drug formulation.

Latest Patents

Harn's latest patents include a crystalline polymorph of 7-ethyl-10-hydroxycamptothecin. This polymorph exhibits an X-ray diffraction pattern with peaks at 10.9±0.2, 13.2±0.2, 23.9±0.2, and 26.1±0.2 2-theta degrees. Additionally, he has developed novel crystalline forms of topotecan hydrochloride along with processes for making these forms. These innovations are crucial for enhancing the efficacy and stability of cancer therapies.

Career Highlights

Throughout his career, Harn has worked with Scinopharm Taiwan, Ltd., a company known for its focus on pharmaceutical development. His expertise in crystallography and drug formulation has positioned him as a key player in the industry.

Collaborations

Harn has collaborated with notable colleagues such as Shu-Ping Chen and Tsung-Cheng Hu. These partnerships have fostered a collaborative environment that encourages innovation and the advancement of pharmaceutical sciences.

Conclusion

Piin-Jye Harn's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment and drug formulation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…